CN Stock MarketDetailed Quotes

Shandong Jincheng Pharmaceutical Group (300233)

Watchlist
  • 15.42
  • -0.09-0.58%
Market Closed Apr 10 15:00 CST
5.92BMarket Cap134.09P/E (TTM)

Shandong Jincheng Pharmaceutical Group (300233) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Preparation product928.7M33.93%
Other699.93M25.57%
Cefazal side chain active ester series596.35M21.79%
Series of Biopharmaceutical and characteristic API products511.95M18.71%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry2.74B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic sales2.27B82.94%
Foreign sales466.8M17.06%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More